FOXP3 and Huntington disease: Expanded ex vivo cells demonstrated the immune profile of Tregs: 88.6–92.1% of cells had a CD127low immunophenotype (Figure 2A,B), and 96.6–97.7% of them were FoxP3-positive (Figure 2C,D) for both the MS and HD groups.